309 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CLNX | €31.86 | 0.03% | -3.9% | €22.5b | €44.23 | PS5.6x | E65.4% | 0.2% | Telecom | ||
MRO New | UK£6.32 | 1.3% | 3.5% | UK£8.1b | UK£6.55 | PS2.3x | E100.9% | 0.9% | Capital Goods | ||
ORSTED New | DKK 300.80 | 0.8% | -24.3% | DKK 126.4b | DKK 379.50 | PS1.8x | E32.0% | 0% | Utilities | ||
APG | US$37.50 | -2.6% | 7.4% | US$10.4b | US$44.00 | PS1.5x | E103.6% | n/a | Capital Goods | ||
COHR | US$86.80 | -9.5% | 45.3% | US$13.5b | US$115.97 | PS2.5x | E88.4% | n/a | Tech | ||
DKNG | US$53.49 | 26.5% | 20.0% | US$26.2b | US$54.81 | PS5.5x | E50.6% | n/a | Consumer Services | ||
000002 | CN¥7.81 | 5.3% | -22.4% | CN¥87.8b | CN¥7.43 | PS0.2x | E88.5% | 0% | Real Estate Management and Development | ||
DLTR | US$71.56 | -1.5% | -50.1% | US$15.4b | US$84.09 | PS0.5x | E33.2% | n/a | Consumer Retailing | ||
1COV | €58.56 | 1.3% | 21.6% | €11.1b | €61.82 | PS0.8x | E62.7% | 0% | Materials | ||
GALD | CHF 112.54 | -2.7% | n/a | CHF 26.7b | CHF 107.26 | PS6.9x | E36.6% | n/a | Pharmaceuticals & Biotech | ||
4755 | JP¥1,023.00 | 3.3% | 31.4% | JP¥2.2t | JP¥983.00 | PS1x | E70.5% | 0% | Retail | ||
2002 New | NT$23.25 | 18.3% | -6.6% | NT$354.5b | NT$23.58 | PE90.7x | E62.2% | 1.5% | Materials | ||
Z74 | S$3.36 | 2.4% | 41.2% | S$55.4b | S$3.72 | PS3.9x | E34.5% | 5.0% | Telecom | ||
UN0 | €43.65 | 3.4% | -22.1% | €18.2b | €34.83 | PS0.2x | E58.7% | 0% | Utilities | ||
ROKU | US$99.07 | 16.6% | 37.6% | US$14.4b | US$100.06 | PS3.5x | E62.0% | n/a | Media | ||
TRU New | US$99.74 | 4.9% | 32.9% | US$19.5b | US$117.60 | PE68.4x | E27.6% | 0.5% | Commercial Services | ||
ILMN | US$100.24 | -9.7% | -30.1% | US$15.9b | US$147.56 | PS3.6x | E56.7% | 3.1% | Pharmaceuticals & Biotech | ||
GMED | US$83.93 | -4.2% | 55.9% | US$11.4b | US$97.85 | PE124.9x | E49.1% | n/a | Healthcare | ||
NPN New | R4,600.00 | 12.3% | 39.2% | R763.0b | R5,709.04 | PE12x | E19.8% | 0.3% | Retail | ||
PHIA | €27.02 | 1.6% | 47.7% | €25.2b | €28.66 | PS1.4x | E63.0% | n/a | Healthcare | ||
A035720 | ₩38,750.00 | -12.9% | -33.6% | ₩17.0t | ₩46,671.43 | PS2.1x | E63.2% | 0.2% | Media | ||
GFS | US$43.16 | 12.2% | -19.1% | US$23.9b | US$47.79 | PS3.5x | E42.0% | n/a | Semiconductors | ||
UCB | €180.45 | -4.6% | 90.1% | €34.2b | €202.88 | PE142.6x | E28.4% | 0.8% | Pharmaceuticals & Biotech | ||
TWLO | US$125.17 | -14.1% | 113.6% | US$19.2b | US$140.70 | PS4.3x | E48.6% | n/a | Software |